Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NewAmsterdam Pharma Co N.V. | Chief Accounting Officer | Ordinary Shares | 15K | $376K | $25.09 | Sep 3, 2025 | Direct |
NewAmsterdam Pharma Co N.V. | Chief Accounting Officer | Option (right to buy) | 280K | Sep 9, 2025 | Direct | ||
NewAmsterdam Pharma Co N.V. | Chief Accounting Officer | Restricted Stock Unit | 0 | Mar 26, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NAMS | NewAmsterdam Pharma Co N.V. | Sep 9, 2025 | 4 | -$2.37M | 4 | Sep 10, 2025 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Sep 3, 2025 | 1 | -$453K | 4 | Sep 5, 2025 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Sep 2, 2025 | 2 | $0 | 4 | Sep 4, 2025 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Aug 25, 2025 | 1 | -$206K | 4 | Aug 27, 2025 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Mar 26, 2025 | 3 | $0 | 4 | Mar 28, 2025 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Mar 4, 2025 | 3 | -$3.06M | 4 | Mar 5, 2025 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Jan 7, 2025 | 1 | $0 | 4 | Jan 7, 2025 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Jan 2, 2025 | 1 | $0 | 4 | Jan 6, 2025 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Sep 27, 2024 | 3 | -$707K | 4 | Oct 1, 2024 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Dec 29, 2023 | 0 | $0 | 3 | Dec 29, 2023 | Chief Accounting Officer |